← 返回

NK 细胞表达的含 ITAM 受体在癌症中的作用

英文原题:Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer.

查看英文原题

Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer.

PubMed 2022/06/10(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

自然杀伤(NK)细胞是先天淋巴样细胞(ILC),能够识别并直接杀伤肿瘤细胞。它们还分泌细胞因子和趋化因子,参与塑造适应性免疫应答。NK细胞识别肿瘤细胞,并通过抑制性受体和激活性受体的净正信号被激活。若干激活性NK细胞受体与含有免疫受体酪氨酸基激活基序(ITAM)的衔接分子偶联。这些受体包括CD16以及人类中的自然细胞毒性受体NKp46、NKp44、NKp30。这些激活性受体所触发的强大抗肿瘤NK细胞应答,使其成为免疫治疗中极具吸引力的靶点。在本综述中,我们将讨论NK细胞上表达的与含ITAM的细胞表面受体相关的不同激活性受体、它们在肿瘤环境中的调控,以及为增强癌症患者NK细胞应答而开发的各种治疗工具。

展开英文摘要原文

Natural Killer (NK) cells are innate lymphoid cells (ILCs) capable of recognizing and directly killing tumor cells. They also secrete cytokines and chemokines, which participate in the shaping of the adaptive response. NK cells identify tumor cells and are activated through a net positive signal from inhibitory and activating receptors. Several activating NK cell receptors are coupled to adaptor molecules containing an immunoreceptor tyrosine-based activation motif (ITAM).

These receptors include CD16 and the natural cytotoxic receptors NKp46, NKp44, NKp30 in humans. The powerful antitumor NK cell response triggered by these activating receptors has made them attractive targets for exploitation in immunotherapy. In this review, we will discuss the different activating receptors associated with ITAM-bearing cell surface receptors expressed on NK cells, their modulations in the tumor context and the various therapeutic tools developed to boost NK cell responses in cancer patients.

论文信息

作者
Medjouel Khlifi H、Guia S、Vivier E、Narni-Mancinelli E
单位
Aix-Marseille Université, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Immunologie de Marseille-Luminy (CIML), Marseille, France.France
文献类型
综述 · 非美国政府资助研究
期刊
Frontiers in immunology2022
原文标识
PubMed 35757695 · DOI 10.3389/fimmu.2022.898745